Skip to content
Riskpilot
← Back to search
Sign in
Get full access
Sana Pharma Sweden AB
AB
Active
Org 5592756687
Svärdvägen 21, 182 33
Danderyd
Retail sale of pharmaceutical products
· NACE 4773
Est. 2020
0 employees
Watchlist
Share
Sweden
/
Companies
/
Retail sale of pharmaceutical products
/
Sana Pharma Sweden AB
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
SEK millions
0M
0M
1M
1M
1M
0M
2021
0M
2022
0M
2023
0M
2024
EBITDA
SEK millions
0M
0M
1M
1M
1M
-4M
2021
-2M
2022
0M
2023
0M
2024
Income statement
SEK thousands
Item
2021
2022
2023
2024
Revenue
0
0
0
0
Staff expenses
—
—
—
—
EBITDA
−4 254
−2 376
−82
−193
Depreciation & amort.
−0
−0
−0
−0
EBIT
−4 254
−2 376
−82
−193
Net financials
—
1
17
−40
Profit before tax
−4 254
−2 375
−65
−233
Tax
−0
−0
−0
−0
Net profit
−4 254
−2 375
−65
−233
Balance sheet
SEK thousands
Item
2021
2022
2023
2024
Total assets
208 633
209 309
208 901
207 921
Equity
205 710
203 335
203 271
203 038
Long-term debt
0
0
0
0
Short-term debt
2 923
5 973
5 630
4 883
Total debt
2 923
5 973
5 630
4 883
Financial ratios
5-year trend
EBITDA margin
-19300000.0%
This company
15.8%
Market median
-122151999% vs market
2021
2024
Equity ratio
97.7%
This company
38.2%
Market median
+156% vs market
2021
2024
Return on equity
-0.1%
This company
18.4%
Market median
-101% vs market
2021
2024
Net profit margin
-23300000.0%
This company
8.1%
Market median
-287654421% vs market
2021
2024
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
2021
2024
Debt / equity
0.02×
This company
0.62×
Market median
+97% vs market
2021
2024
Annual reports & filings
Annual report 2024
Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via Bolagsverket / SCB · Period 2020-10-01 – 2021-12-31
View
PDF
More on Sana Pharma Sweden AB
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network